| 1/26 | US=22 / Câncer Wong KK, Sharpless NE, DePinho RA. Telomeres, telomerase, and cell immortalization. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 53-66. ENVELHECIMENTO E PREVENCAO DO CANCER; TELOMERES/TELOMERASE; TELOMERE MANUTENCAO E CANCER; INSTABILIDADE INDUCAO-TELOMERE; CUSTOS DO ENVELHECIMENTO; TELOMERESE ENVELHECIMENTO |
| 2/26 | US=66 / Biol/Mol Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. 373 p. (Cancer Drug Discovery and Development). ISBN 978-1-60327-306-0. |
| 3/26 | US=102 / Câncer Else T, Hornsby PJ. Telomeres and telomerase in adrenocortical carcinoma. In: Hammer GD, Else T. Adrenocortical carcinoma: basic science and clinical concepts. New York: Springer, 2011. p. 207-25. ISBN 978-0-387-77235-6. CARCINOMA ADRENOCORTICAL; TELOMERES; EXTREMIDADES EXTERNAS DE CROMOSSOMOS; COMPOSICAO; ESTRUTURA; CARCINOGENESE; TELOMERASE; SINDROMES HUMANAS |
| 4/26 | US=66 / Biol/Mol Hiyama K, Hiyana E, Shay JW. Telomeres and telomerase in humans. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 3-21. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. TELOMEROS E TELOMERASE EM HUMANOS; TELOMEROS; TELOMERASE; CELULA GERMINAL; CELULA CANCEROSA; CELULAS-TRONCO; IMORTALIZACAO CELULAR; TELOMERO DISFUNCAO; FIM-REPLICACAO PROBLEMA; STAFE MORTALIDADE; LIMITE DE HAYFLICK; FIM-REPLICACAO PROBLEMA; FASE DE MORTALIDADE; LIMITE DE HAYFLICK; TERT; TERC |
| 5/26 | US=66 / Biol/Mol Dimitrova N. Telomere-binding proteins in humans. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 23-46. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. TELOMERE PROTEINAS DE LIGACAO EM HUMANOS; SHELTERIN; T-LOOP; CAIXA ELETRONICO; ATR; NHEJ; HR |
| 6/26 | US=66 / Biol/Mol Drpcrynski AY, Sachs PC, Elmore LW, Holt SE. Regulation of telomere through transcriptional and posttranslational mechanisms. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 47-85. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. TELOMERASE; ENVELHECIMENTO; QUIMIOTERAPICOS; TRANSCRICAO; TELOMERO |
| 7/26 | US=66 / Biol/Mol Diehl MC, Elmore LW, Holt SE. Telomere dysfunction and the DNA damage response. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 87-125. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. TELOMERE DISFUNCAO E RESPOSTA A DANOS DO DNA; TELOMERO PROTEINAS DE LIGACAO; MANUTENCAO DOS TELOMEROS; DISFUNCAO; DANOS NO DNA; INSTABILIDADE GENOMICA |
| 8/26 | US=66 / Biol/Mol Pickett HA, Reddel RR. Alternative lengthening of telomeres in human cells. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 127-48. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. ALTERNATIVA ALONGAMENTO DOS TELOMEROS EM CELULAS HUMANAS; TELOMERO; MECANISMO DE MANUTENCAO DOS TELOMEROS; ALTERNATIVA ALONGAMENTO DOS TELOMEROS; RECOMBINACAO HOMOLOGA; ALT-ASSOCIADOS CORPOS PML |
| 9/26 | US=66 / Biol/Mol Huang X, Ju Z. Mouse model: telomeres and telomerase in stem cell and cancer. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 149-80. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. TELOMEROS E DA TELOMERASE EM CELULAS-TRONCO E CANCER; TELOMERO; CELULAS-TRONCO; CANCER |
| 10/26 | US=66 / Biol/Mol Hiyama E, Hiyama H. Diagnostic value I: solid tumors. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 181-210. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. TUMORES SOLIDOS; TELOMERASE; TRANSCRIPTASE REVERSA HUMANA TELOMERASE; TERT; ASPIRATIVA POR AGULHA FINA; CITOLOGIA; PROTOCOLO DE AMPLIFICACAO TELOMERICA REPETICAO; TRAP; DIAGNOSTICO; PROGNOSTICO; HIBRIDIZACAO IN SITU; ISH; IMUNO-HISTOQUIMICA; IHC |
| 11/26 | US=66 / Biol/Mol Ohyashiki JH, Ohyashiki K. Diagnostic value II: hematopoietic malignancies. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 211-24. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. DOENCAS MALIGNAS HEMATOPOIETICAS; TELOMEROS; CELULAS ESTAMINAIS HEMATOPOIETICAS; LEUCEMICAS DE CELULAS-TRONCO |
| 12/26 | US=66 / Biol/Mol Herbert BS, Goldblatt EM. Therapeutic targets and drugs I: telomerase and telomerase inhibitors. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 225-49. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. ALVOS TERAPEUTICOS E DROGAS I; INIBIDORES DA TELOMERASE; TELOMERASE; HTERT; HTERC; TELOMERASE INIBIDORES DE TELOMERASE DE ATIVIDADE; TELOMEROS; OLIGONUCLEOTIDEOS; TELOMERASE PROTEINAS ASSOCIADAS; CANCER; ENSAIOS CLINICOS |
| 13/26 | US=66 / Biol/Mol Punchihewa C, Yang D. Therapeutic targets and drugs II: G-quadruplex and G-quadruplex inhibitors. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 251-80. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. ALVOS TERAPEUTICOS E MEDICAMENTOS II; G-QUADRUPLEX E G-QUADRUPLEX INIBIDORES; TELOMERO HUMANO; G-QUADRUPLEX; META DROGA ANTICANCER; G-QUADRUPLEX LIGANTES; POLIMORFISMO ESTRUTURA TELOMERICA G-QUADRUPLEX |
| 14/26 | US=66 / Biol/Mol Seimiya H, Tsuruo T. Therapeutic targets and drugs III: tankyrase 1, telomere-binding proteins, and inhibitors. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 281-91. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. ALVOS TERAPEUTICOS E DROGAS III; TELOMERO PROTEINAS DE LIGACAO E INIBIDORES; TANKYRASE 1; TRF1; POLY(ADP-RIBOSIL); SHELTERIN; TRF2; POT1 |
| 15/26 | US=66 / Biol/Mol Fujiwara T, Urata Y, Tanaka N. Therapeutic targets and drugs IV: telomerase-specific gene and vector-based therapies for human cancer. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 293-312. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. ALVOS TERAPEUTICOS E MEDICAMENTOS IV; TERAPIAS TELOMERASE ESPECIFICA DE GENES. BASEADO EM VETOR PARA O CANCER HUMANO; TELOMERASE; HTERT; ADENOVIRUS; GFP; IMAGEM |
| 16/26 | US=66 / Biol/Mol Hiyama E. Protocol I: telomerase activity and telomerase expression. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 315-35. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. PROTOCOLO I; ATIVIDADE DA TELOMERASE; EXPRESSAO DA TELOMERASE; TRAP; TELOMERASE; TERT; TERC; TECNICAS DE DETECCAO IN SITU |
| 17/26 | US=66 / Biol/Mol Shimamoto A, Aoki E, Sera AM, Tahara H. Protocol II: importance and methods of telomere G-tail length quantification. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 337-50. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. PROTOCOLO II; QUANTIFICACAO DOS TELOMEROS DE COMPRIMENTO G-TAIL; COMPRIMENTO TOLOMERE; G-TAIL TELOMERO HPA; TELOMERO - A LIGACAO AS PROTEINAS; DANOS NO DNA; APOPTOSE; PENT; T-OLA; PREMATURA SINDROME DE ENVELHECIMENTO; RELACIONADA COM A IDADE DOENCA |
| 18/26 | US=66 / Biol/Mol Jiang WQ, Henson JD, Neumann AA, Reddel RR. Protocol III: detection of alternative lengthening of telomeres. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 351-64. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. PROTOCOLO III; TELOMERO ALONGAMENTO; TELOMEROS; ALTERNATIVA ALONGAMENTO DOS TELOMEROS; ALT; ALT-ASSOCIADOS CORPOS PML; APBS; PML; METODO |
| 19/26 | US=13 / Biol/Mol Pecorino L. Regulation of gene expression. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 47-68. ISBN 978-0-19-921148-7. REGULACAO DA EXPRESSAO GENICA; FATORES DE TRANSCRICAO; REGULACAO TRANSCRICIONAL; ESTRUTURA DA CROMATINA; REGULACAO EPIGENETICA DA TRANSCRICAO; MODIFICACAO DA HISTONA; METILACAO DE DNA; EPIGENETICA; CARCINOGENESE; TELOMERES; TELOMERASE |
| 20/26 | US=53 / Biol/Mol Sandberg A, Stone JF. Key mechanisms and pathways. In: ___. The genetics and molecular biology of neural tumors. New Jersey: Humana Press, 2008. p. 431-43. ISBN 978-1-59745-510-7. TUMORES NEURAIS; VIAS MOLECULARES; TP53; RB; WNT; SHH; EGFR; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; TELOMERES; TELOMERASE; EPIGENETICA; CICLO CELULAR; APOPTOSE |